Molecular approaches to neuroendocrine pathology

Cancer and Metastasis Reviews

Volumn 16, Issue 1-2, 1997, Pages 179-205

  Steel, Jennifer H ^a   Bishop, Anne E ^b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

bioactive substances; diagnosis; differentiation; molecular pathology; neuroendocrine tumours; prognosis

Indexed keywords

HUMAN; MOLECULAR GENETICS; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEUROENDOCRINE TUMORS; ONCOGENES; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 0030990305     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005712828667     Document Type: Review

References (149)

1. Waldum HL, Brenna E, Kleveland PM, Sandvik AK, Syversen U: The role of gastric acid inhibitory drugs - physiological and pathophysiological considerations. Aliment Pharm Ther 7: 589-596, 1993
2. Waldum HL, Sandvik AK, Syversen U, Brenna E: The enterochromaffin-like cell - physiological and pathophysiological role. Acta Oncol 32: 141-147, 1993
3. Damjanov I, Amenta PS, Bosman FT: Undifferentiated carcinomas of the colon containing exocrine, neuroendocrine and squamous cells. Virchows Archiv A Pathol Anat 40: 57-66, 1983
4. Gibbs NM: Incidence and significance of argentaffin and Paneth cells in some tumours of the large intestine. J Clin Pathol 20: 826-831, 1967
5. Gropp C, Havemann K, Scheuer A: Ectopic hormones in lung cancer patients at diagnosis and during therapy. Cancer 46: 347-354, 1980
6. Onishi R, Sano T, Nakamura Y, Sawada S, Ihara C, Shimatsu A: Ectopic adrenocorticotropin syndrome associated with undifferentiated carcinoma of the colon showing multidirectional neuroendocrine, exocrine, and squamous differentiation. Virchows Arch 427: 537-541, 1996
7. Larsson L-I: Classification of pancreatic endocrine tumours. Scand J Gastroenterol Suppl 53: 15-18, 1979
8. Mathew CGP, Chin KS, Easton DF, Thorpe K, Carter C, Liou GI, Fong S-L, Bridges CDB, Haak H, Nieuwenhuijzen Kruseman AC, Schifter S, Hansen HH, Telenius H, Telenius-Berg M, Ponder BAJ: A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328: 527-528, 1987
9. Simpson NE, Kidd KK, Goodfellow PJ, McDermic H, Myers S, Kidd JR, Jackson CE, Duncan AMV, Farrer LA, Brasch K, Castiglione C, Genel M, Gertner J, Greenberg CR, Gusella JF, Holden JJA, White BN: Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 328: 518-530, 1987
10. Durbec P, Marcos-Gutierrez CV, Kilkenny C, Grigcriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M, Sariola H, Pachnis V: GDNF signalling through the Ret receptor tyrosine kinase. Nature 381: 789-793, 1996
11. Trupp M, Arenas E, Fainzilber M, Nillson A-S, Sieber B-A, Grigoriou M, Kilkenny C, Salazar-Grueso E, Pachris V, Arumae U, Sariola H, Saarma M, Ibanez CF: Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381: 785-789, 1996
12. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L: Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458-460, 1993
13. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA Jr: Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum Mol Genet 2: 851-856, 1993
14. Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Hoppener JWM, van Amstel HKP, Romeo G, Lips CJM, Buys CHCM: A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367: 375-376, 1994
15. van Heymingen V: One gene - four syndromes. Nature 367: 319-320, 1994
16. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M: Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332: 85-87, 1988
17. Brandi ML, Aurbach GD, Fitzpatrick LA, Quarto R, Spiegel AM, Bliziotes MM, Norton JA, Doppman JL, Marx SJ: Parathyroid mitogenic activity in plasma from patients with multiple endocrine neoplasia type 1. N Engl J Med 314: 1287-1293, 1986
18. Asa SL, Singer W, Kovacs K, Horvath E, Murray D, Colapinto N, Thorner MO: Pancreatic endocrine tumour producing growth hormone-releasing hormone associated with multiple endocrine neoplasia type I syndrome. Acta Endocrinol (Copenh) 115: 331-337, 1987
19. Polak JM, Bloom SR: Review: The enterochromaffin-like cell, intragastric acidity and the trophic effect of plasma gastrin. Aliment Pharmacol Ther 2: 291-296, 1988
20. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fecorko J, Fischler A, Minny JD: Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer. Nature 316: 823-826, 1985
21. Jameson JL, Klibanski A, Black PM, Zervas NT, Lindell TM, Hsu DW, Ridgway EC, Habener JF: Glycoprotein hormone genes are expressed in clinically malfunctioning pituitary adenomas. J Clin Invest 80: 1472-1478, 1987
22. Levy A, Lightman SL: Quantitative, in situ hybridization histochemistry of anterior pituitary hormone mRNA species in human pituitary adenomas. Acta Endocrinol 119: 397-404, 1988
23. McNicol AM, Walker H, Farquharson MA, Teasdale GM: Pituitary macroadenomas associated with hyperprolactinaemia: Immunocytochemical and in situ hybridization studies. Clin Fndocrinol 35: 239-244, 1991
24. Ridgway EC, Klibanski A, Ladenson PW, Clemmons D, Beitins IZ, McArthur JW, Martorana MA, Zervas NT: Pure alpha-secreting pituitary tumors. N Engl J Med 304: 1254-1259, 1981
25. Jameson JL, Weiss J, Polak JM, Childs GV, Bloom SR, Steel JH, Capen CC, Prentice DE, Fetter AW, Langloss JM: Glycoprotein hormone alpha-subunit-producing pituitary adenomas in rats treated for one year with calcitonin. Am J Pathol 140: 75-84, 1992
26. Heitz PU, Von-Herbay G, Kloppel G, Komminoth P, Kasper M, Hofler H, Muller KM, Oberholzer M: The expression of subunits of human chorionic gonadotropin (hCG) by nontrophoblastic, nonendocrine, and endocrine tumors. Am J Clin Pathol 88: 467-472, 1987
27. Kloppel G, Girard J, Polak JM, Vaitukaitis JL., Kasper M, Heitz PU: Alpha-human chorionic gonadotrophin and neuron-specific enolase as markers for malignancy and neuroendocrine nature of pancreatic endocrine tumours. Cancer Detect Prev 6: 161-166, 1983
28. Fukayama M, Hayashi Y, Shiozawa Y, Furukawa E, Funata N, Koike M: Human chorionic gonadotropin alpha-subunit in endocrine cells of librotic and neoplastic lung. Its mode of localization and the size profile of granules. Lab Invest 62: 444-451, 1990
29. Fukayama M, Hayashi Y, Shiozawa Y, Okabe S, Koike M: Human chorionic gonadotropin alpha-subunit in rectal carcinoids. Its mode of presence and the change of granule morphology. Am J Pathol 135: 1065-1072, 1989
30. Perkins PL, McLeod MK, Jin L, Fukuuchi A, Cho KJ, Thompson NW, Lloyd RV: Analysis of gastrinomas by immunohistochemistry and in situ hybridization histochemistry. Diagn Mol Pathol 1: 155-164, 1992
31. Kumar S, Talwar GP, Biswas DK: Necrosis and inhibition of growth of human lung tumor by anti-alpha-human chorionic gonadotropin antibody. J Natl Cancer Inst 84: 42-47, 1992
32. Kourides IA, Wientraub BD, Rosen SW, Ridgway EC, Kliman B, Maloof F: Secretion of alpha subunit of glycoprotein hormones by pituitary adenomas. J Clin Endocrinol Metab 43: 97-106, 1976
33. Saccomanno K, Spada A, Bassetti M, Gil del Alamo P, Faglia G: Immunodetection of chorionic gonadotrophin and its subunits in human nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 78: 1103-1107, 1994
34. Houben H, Denef C: Bioactive peptides in anterior pituitary cells. Peptides 15: 547-582, 1994
35. Denef C, Baes M, Schramme C: Paracrine interactions in the anterior pituitary: Role in the regulation of prolactin and growth hormone secretion. In: Ganong WF, Martini L (eds) Frontiers in Neuroendocrinology, Vol 9. Raven Press, New York, 115-148, 1986
36. Jones TH, Brown BL, Dobson PRM: Paracrine control of anterior pituitary secretion. J Endocrinol 127: 5-13, 1990
37. O'Halloran DJ, Jones PM, Bloom SR: Neuropeptides synthesised in the anterior pituitary: Possible paracrine role. Mol Cell Endocrinol 75: C7-C12, 1991
38. Steel JH, Van Noorden S, Ballesta J, Gibson SJ, Ghatei MA, Burrin J, Leonhardt U, Domin J, Bloom SR, Polak JM: Localization of 7B2, neuromedin B, and neuromedin U in specific cell types of rat, mouse and human pituitary, in rat hypothalamus and in 30 human pituitary and extra-pituitary tumors. Endocrinology 122: 270-282, 1988
39. Steel JH, O'Halloran DJ, Emson MA, Van Noorden S, Bloom SR, Polak JM: Identification of bombesin-imunoreactive cells in rat, human and other mammalian pituitaries, their ontogeny and the effect of endocrine manipulations in the rat. Endocrinology 130: 2587-2596, 1992
40. Gon G, Giaid A, Steel JH, O'Halloran DJ, Van Noorden S, Ghatei MA, Jones PM, Amara SG, Ishikawa H, Bloom SR, Polak JM: Localization of immunoreactivity for calcitonin gene-related peptide in the rat anterior pituitary during ontogeny and gonadal steroid manipulations and detection of its messenger RNA. Endocrinology 127: 2618-2629, 1990
41. Vrontakis ME, Sano T, Kovacs K, Friesen HG: Presence of galanin-like immunoreactivity in nontumorous corticotrophs and corticotroph adenomas of the human pituitary. J Clin Endocrinol Metab 70: 747-751, 1990
42. Polak JM, Gibson S, Gentleman S, Steel J, Van Noorden S: Galanin: Distribution, ontogeny and expression following manipulation of the endocrine and nervous systems. In: Hokfelt T, Bartfai T, Jacobowitz D, Ottoson D (eds) Galanin: A New Multifunctional Peptide in the Neuro-endocrine System. Macmillan Press, London, 117-134, 1991
43. Levy A, Lightman SL: Growth hormone-releasing hormone transcripts in human pituitary adenomas. J Clin Endocrinol Metab 74: 1474-1476, 1992
44. Le Dafniet M, Lefebvre P, Barret A, Mechain C, Feinstein MC, Brandi AM: Normal and adenomatous human pituitaries secrete thyrotropin releasing hormone in vitro: Modulation by dopamine, haloperidol and somatostatin. J Clin Endocrinol Metab 71: 480-486, 1990
45. Levy A, Lightman SL: Local production of hypothalamic trophic peptides in human pituitary tumours. Clin Chem Enzym Comms 5: 265-273, 1993
46. Bishop AE, Power RF, Polak JM: Markers for neuroendocrine differentiation. Pathol Res Pract 183: 119-128, 1988
47. Kovacs K, Horvath E: Tumours of the pituitary gland. In: Hartmann WH, Sobin LH (eds) Atlas of Tumor Pathology. Fascile 21, Second Series. Armed Forces Institute of Pathology, Washington, 1986
48. Solcia E, Capella C, Buffa R.,Frigero B, Usellini L, Fiocca R, Tenti P, Sessa F, Rindi G: Cytology of tumours in the gastroenteropancreatic and diffuse neuroendocrine system. In: Falkmer S, Hakanson R, Sundler F (eds) Cytology of Tumours of the Neuroendocrine System. Elsevier, Amsterdam, 453-480, 1984
49. Trembleau A, Bloom FE: Enhanced sensitivity for light and electron microscopic in situ hybridization with multiple simultaneous non-radioactive oligodeoxynucleotide probes. J Histochem Cytochem 43: 829-841, 1995
50. Kendall CH, Roberts PA, Pringle JH, Lauder I: The expression of parathyroid hormone messenger RNA in normal and abnormal parathyroid tissue. J Pathol 165: 111-118, 1991
51. Black M, Carey FA, Farquharson MA, Murray GD, McNicol AM: Expression of the pro-opiomelanocortin gene in lung neuroendocrine tumours: In situ hybridization and immunocytochemical studies. J Pathol 169: 329-334, 1993
52. Normand E, Bloch B: Simultaneous detection of two messenger RNAs in the central nervous system: A simple two-step in situ hybridization procedure using a combination of radioactive and non-radioactive probes. J Histochem Cytochem 39: 1575-1578, 1991
53. Trembleau A, Roche D, Calas A: Combination of non-radioactive and radioactive in situ hybridization with immunohistochemistry: A new method allowing the simultaneous detection of two mRNAs and one antigen in the same brain tissue section. J Histochem Cytochem 41: 489-498, 1993
54. Ballard SG, Ward DC: Fluorescence in situ hybridization using digital imaging microscopy. J Histochem Cytochem 41: 1755-1760, 1993
55. Honer H, Putz B, Ruhri C., Wirnsberger G, Klimpfinger M, Smolle J: Simultaneous localization of calcitonin mRNA and peptide in a medullary thyroid carcinoma. Virchows Arch B 54: 144-151, 1987
56. Chan-Palay V, Yasargil G, Hamid Q, Polak JM, Palay SL: Simultaneous demonstrations of neuropeptide Y gene expression and peptide storage in single neurons of the human brain. Proc Natl Acad Sci USA 85: 3213-3215, 1988
57. Ironside J W, Lewis FA, Blythe D, Wakefield EA: The identification of cells containing JC papovirus DNA in progressive multifocal leukoencephalopathy by combined in situ hybridization and immunocytochemistry. J Pathol 157: 291-297, 1989
58. Steel JH, O'Halloran DJ, Jones PM, Van Noorden S, Chin WW, Bloom SR, Polak JM: Combined use of immunocytochemistry and in situ hybridization to study β thyroid-stimulating hormone gene expression in pituitaries of hypothyroid rats. Mol Cell Probes 4: 385-396, 1990
59. Hamid O, Corrin B, Sheppard MN, Huttner WB, Polak JM: Expression of chromogranin A mRNA in small cell carcinoma of the lung. J Pathol 163: 293-297, 1991
60. Reubi JC, Landholt AM: High density of somatostatin receptors in pituitary tumours from acromegalic patients. J Clin Endocrinol Metab 59: 1148-1151, 1984
61. Reubi JC: Neuropeptide receptors in health and disease: The molecular basis for in vivo imaging. J Nucl Med 36: 1825-1835, 1995
62. Reubi JC: In vitro identification of vasoactive intestinal peptide receptors in human tumours: Implications for tumour imaging. J Nucl Med 36: 1846-1853, 1995
63. Virgolini I, Raderer M, Kurtaran A, Angelberger P, Banyai S, Yang O, Li S, Banyai M, Pidlich J, Niederle B, Scheithauer W, Valent P: Vasoactive intestinal peptide receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumours. N Engl J Med 331: 1116-1121, 1994
64. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487-491, 1988
65. Komminoth P, Kunz E, Hiort O, Schröder S, Matias-Guiu X, Christiansen G, Roth J, Heitz PU: Detection of RET proto-oncogene point mutations in paraffin-embedded phaeochromocytoma specimens by non-radioactive single strand conformation polymorphism analysis and direct sequencing. Am J Pathol 145: 922-929, 1994
66. Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967-971, 1992
67. Bertoli DJ, Schlichter UHA, Adams MJ, Burrows PR, Steinbiß HH, Antoniw JF: An analysis of differential display shows a strong bias towards high copy number mRNAs. Nucl Acids Res 23: 4520-4523, 1995
68. Diel P, Walter A, Fritzemeier KH, Hegele-Hartung, C, Knauthe R: Identification of estrogen regulated genes in Fe33 rat hepatoma cells by differential display polymerase chain reaction and their hormonal regulation in rat liver and uterus. J Steroid Biochem Mol Biol 55: 363-373, 1995
69. Lebel M, Bertrand R, Mes-Masson AM: Decreased Fas antigen receptor expression in testicular tumor cell lines derived from polyomavirus large T-antigen transgenic mice. Oncogene 12: 1127-1135, 1996
70. Brady G, Iscove NN: Construction of cDNA libraries from single cells. Methods Enzymol 225: 611-623, 1993
71. Komminoth P, Long AA: In-situ polymerase chain reaction: An overview of methods, applications and limitations of a new molecular technique. Virchows Arch B Cell Pathol 64: 67-73, 1993
72. Martínez A, Miller MJ, Unsworth EJ, Siegfried JM, Cuttitta F: Expression of adrenomedullin in normal lung and in pulmonary tumors. Endocrinology 136: 4099-4105, 1995
73. O'Leary JJ, Chetty R, Graham AK, McGee JO'D: In situ PCR: Pathologist's dream or nightmare? J Pathol 178: 11-20, 1996
74. Mee AP, Hoyland JA, Braidman IP, Freemont AJ, Davies M, Mawer EB: Demonstration of vitamin D receptor transcripts in actively resorbing osteoclasts in bone sections. Bone 18: 295-299, 1996
75. Koch JE, Kolvraa S, Petersen KB, Gregersen N, Bolund L: Oligonucleotide-priming methods for the chromosome-specific labelling of alpha satellite DNA in situ. Chromosoma 98: 259-265, 1989
76. Gosden J, Hanratty D, Starling J, Fantes J, Mitchell A, Porleus D: Oligonucleotide primed in situ DNA synthesis (PRINS): A method for chromosome mapping, banding and investigation of sequence organisation. Cytogenet Cell Genet 57: 100-104, 1991
77. Tecott LH, Barchas JD, Eberwine JH: In situ transcription: Specific synthesis of complementary DNA in fixed tissue sections. Science 240: 1661-1664, 1988
78. Wang B-L, Grammas P, Ringer DP, Kong J, DeBault LE: Localization of γ-glutamyl transpeptidase and its mRNA in a spontaneous tube-forming clone of endothelial cells from rat cerebral resistance-vessel endothelium. Cell Vision 2: 196-202, 1995
79. Cinti C, Santi S, Maraldi NM: Localisation of single copy gene by PRINS technique. Nucleic Acids Res 21: 5799-5800, 1993
80. Gosden J, Hanratty D: PCR in situ: A rapid alternative to in situ hybridization for mapping short, low copy number sequences without isotopes. BioTechniques 15: 78-80, 1993
81. Hofland LJ, Velkeniers B, Van Koetsveld PM, Hooghe-Peters EL, Lamberts SW: The relationship between growth hormone (GH) messenger ribonucleic acid levels and hormone release from individual cells derived from human GH-secreting pituitary adenomas. Clin Endocrinol 34: 5-11, 1991
82. Kendall ME, Hymer WC: Measurement of hormone secretion from individual cells by cell blot assay. Methods Enzymol 168: 327-338, 1989
83. Cimini V, Van Noorden S, Mahadeva H, Polak JM: The cell blot assay in analysis of rat anterior pituitary cell secretion. Histochem J 26: 59-66, 1994
84. Sheard JD, Gosney JR: Endocrine cells in tumor-bearing lungs. J Palhol 168 (Suppl): 156A, 1992
85. Baes M, Allaerts W, Denel C: Evidence for functional communication between folliculo-stellate cells and hormone-secreting cells in perifused anterior pituitary cell aggregates. Endocrinology 120: 685-691, 1987
86. Linnoila RI, Piantadosi S, Ruckdeschel JC: Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG exprience. Chest 106 (6 Suppl): 367S-371S, 1994
87. Carles J, Rosell R, Ariza A, Pellicer I, Sanchez JJ, Fernandez-Vasalo G, Abad A, Barnadas A: Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer. Lung Cancer 10: 209-219, 1993
88. Hamada Y, Oishi A, Shoji T, Takada H, Yamamura M, Hioki K, Yamamoto M: Endocrine cells and prognosis in patients with colorectal carcinoma. Cancer 69: 2641-2646, 1992
89. Saclarides TJ, Szeluga D, Staren ED: Neuroendocrine cancers of the colon and rectum. Results of a ten-year experience. Dis Colon Rectum 37: 635-642, 1994
90. Steel GG: Growth kinetics of tumours. Oxford University Press, 1977
91. Yu CC-W, Woods AL, Levison DA: The application of immunohistochemistry in assessment of cellular proliferation. In: Hall PA, Levison DA, Wright NA (eds) Assessment of Cell Proliferation in Clinical Practice. Springer-Verlag, London, 141-159, 1992
92. Lloyd RV, Carney JA, Ferreiro JA, Jin L, Thompson GB, vanHeerden JA, Grant CS, Wollan PC: Immunohistochemical analysis of the cell cycle-associated antigens Ki-67 and retinoblastoma protein in parathyroid carcinomas and adenomas. Endocr Pathol 6: 279-287, 1995
93. Chaudhry A, Funa K, Oberg K: Expression of growth factor peptides and their receptors in neuroendocrine tumors of the digestive system. Acta Oncol 32: 107-114, 1993
94. Nilsson O, Wangberg B, Kolby L, Schultz GS, Ahlman H: Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours. Int J Cancer 60: 645-651, 1995
95. Rindi G: Characterisation of neuroendocrine tumours in transgenic mice. Digestion 55 (Suppl 3): 24-30, 1994
96. Drucker DJ: Molecular pathophysiology of glucagon-SV40 T antigen transgenic mice. Am J Physiol 267: E629-E635, 1994
97. Maxwell IH, Maxwell F, Glode LM: Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: A possible strategy for inducing cancer cell suicide. Cancer Res 46: 4660-4664, 1986
98. Behringer RB, Mathews LS, Palmiter RD, Brinster RL: Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes and Develop 2: 453-461, 1988
99. Stefaneanu L, Kovacs K, Horvath E, Losinski NE, Mayerhofer A, Wagner TE, Bartke A: An immunocytochemical and ultrastructural study of adenohypophyses of mice transgenic for human growth hormone. Endocrinology 126: 608-615, 1990
100. Stefaneanu L, Kovacs K, Bartke A: In situ hybridization study of growth hormone, prolactin, and proopiomelanocortin mRNAs in adenohypophyses of mice transgenic for human growth hormone. Endocr Pathol 4: 73-78, 1993
101. Borelli E, Sawchenko PE, Evans RM: Pituitary hyperplasia induced by ectopic expression of nerve growth factor. Proc Natl Acad Sci USA 89: 2764-2768, 1992
102. Murphy D, Bishop AE, Rindi G, Murphy MN, Stamp GW, Hanson J, Polak JM, Hogan B: Mice transgenic for vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type I. Am J Pathol 129: 552-566, 1987
103. Gagel RF, Cote GJ, Martins-Bugalho MJ, Boyd AE 3rd, Cummings T, Goepfert H, Evans DB, Cangir A, Khorana S, Schultz PN: Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A. J Intern Med 238: 333-341, 1995
104. Ledger GA, Khosla S, Lindor NM, Thibodeau SN, Gharib H: Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II. Ann Intern Med 122: 118-124, 1995
105. Carlomagno F, Salvatore D, Santoro M, de-Franciscis V, Quadro L, Panariello L, Colantuoni V, Fusco A: Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell line. Biochem Biophys Res Commun 207: 1022-1028, 1995
106. Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HP, Ponder MA: Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma. Clin Endocrinol Oxf 43: 123-127, 1995
107. Yoshimoto K, Tanaka C, Hamaguchi S, Kimura T, Iwahana H, Miyakuchi A, Itakura M: Tumor-specific mutations in the tyrosine kinase domain of the RET proto-oncogene in phaeochromocytomas of sporadic type. Endocr J 42: 265-270, 1995
108. Tsuda H, Shimosato Y, Upton ME, Yokota J, Terada M, Ohira M, Sugimura T, Hirohashi S: Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation. Lab Invest 59: 321-327, 1988
109. Roncalli M, Viale G, Grimelius L, Johansson H, Wilander E, Alfano RM, Springall DR, Battezzati PM, Polak JM, Coggi G: Prognostic value of N-myc immunoreactivity in medullary thyroid carcinomas. Cancer 74: 134-141, 1994
110. Mabry M, Nakagawa T, Baylin S, Pettengill O, Sorenson G, Nelkin B: Insertion of the v-Ha-ras oncogene induces differentiation of calcitonin-producing human small cell lung cancer. J Clin Invest 84: 194-199, 1989
111. Lee S, Tomasetto C, Sager R: Positive selection of candidate tumor suppressor genes by subtractive hybridization. Proc Natl Acad Sci USA 88: 2825-2829, 1991
112. Hooper ML: The role of the p53 and Rb-1 genes in cancer, development and apoptosis. J Cell Sci Suppl 18: 13-17, 1994
113. Nigro JM, Baker SJ, Preisinger AC, Milburn-Jessup J, Hosteller R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B: Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708, 1989
114. Mitsudomi T, Steinberg SM, Nau MM, Carbone D, D'Amico D, Bodner S, Oie HK, Linnoila RI, Mulshine JL, Minna JD, Gazdar AF: p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7: 171-180, 1992
115. Marshall CJ: Tumor suppressor genes. Cell 64: 313-326, 1991
116. Buckley N, Bates AS, Broome JC. Strange RC, Perrett CW, Burke CW, Clayton RN: p53 protein accumulates in Cushings adenomas and invasive non-functional adenomas. J Clin Endocrinol Metab 80: 692-696, 1995
117. Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AD, Minna JD: p53: A frequent target for genetic abnormalities in lung cancer. Science 246: 491-494, 1989
118. Linzer DIH, Levine AJ: Characterization of a 54 Kdalton cellular SV40 tumour antigen present in SV40 transformed cells and uninfected embryonal carcinoma cells. Cel 17: 43-52, 1979
119. Sumi T, Stefaneanu L, Kovacs K, Asa SL, Rindi G: Immunohistochemical study of p53 protein in human and animal pituitary tumors. Endocr Pathol 4: 95-99, 1993
120. Kumar TR, Donehower LA, Bradley A, Matzuk MM: Transgenic mouse models for tumour-suppressor genes. J Intern Med 238: 233-238, 1995
121. Skogseid B, Larsson C, Oberg K: Genetic and clinical characteristics of multiple endocrine neoplasia type 1. Acta Oncol 30: 485-488, 1991
122. Sagar R, Anisowicz A, Neveu M, Liang P, Sotiropoulou G: Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene. FASEB J 7: 964-970, 1993
123. Pabo CO, Sauer RJ: Transcription factors: Structural families and principles of DNA recognition. Ann Rev Biochem 61: 1053-1095, 1992
124. Li S, Crenshaw BIII, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG: Dwarf locus mutation lacking three pituitary cell types result from mutations in the POU-domain pit-1. Nature 347: 528-533, 1990
125. Voss J W, Rosenfeld MG: Anterior pituitary development: Short tales from dwarf mice. Cell 70: 527-530, 1992
126. Castrillo JL, Theill LE, Karin M: Function of the homeodomain protein GHF-1 in pituitary cell proliferation. Science 253: 197-199, 1991
127. Delhase M, Vergoni P, Malur A, Velkeniers B, Tengels E, Trouillas J, Hooghe-Peters EL: Pit-1/GHF-1 expression in pituitary adenomas: Further analogy between human adenomas and rat SMtTW tumors. J Mol Endocrinol 11: 129-139, 1993
128. Friend KE, Chiou YK, Laws ER Jr, Lopes MBS, Shupnik MA: Pit-1 messenger ribonucleic acid is differentially expressed in human pituitary adenomas. J Clin Endoerinol Melab 77: 1497-1504, 1993
129. Sanno N, Inada K, Utsunomiya H, Umemura S, Itoh Y, Matsuno A, Teramoto A, Osamura RY: Expressior of pit-1 product in human pituitaries: Histochemical studies using an antibody against synthetic human pit-1 protein. Med Sci Res 22: 685-687, 1994
130. Sanno N, Teramoto A, Matsuno A, Inada K, Itoh J, Osamura RY: Clinical and immunohistochemical studies on TSH-secreting pituitary adenoma: Its multihormonality and expression of pit-1. Modern Pathol 7: 893-899, 1994
131. Friend KE, Chiou YK, Lopes MB, Laws ER Jr, Hughes KM, Shupnik MA: Estrogen receptor expression in human pituitary: Correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas. J Clin Endoerinol Metab 78: 1497-1504, 1994
132. Zafar M, Ezzat S, Ramyar L, Pan N, Smyth HS, Asa SL: Cell-specific expression of estrogen receptor in the human pituitary and its adenomas. J Clin Endocrinol Metab 80: 3621-3627, 1995
133. Brenner DG, Magill-Solc C, Spencer DR, Biroc SL, Warner NJ, Dykes DJ: Antitumour activity of neutral endopeptidase (NEP) in nude mouse small cell lung cancer (SCLC) xenograft models. Proc Annu Meet Am Assoc Cancer Res 36: A1582, 1995
134. Eipper BA, Stoffers DA, Mains RE: The biosynthesis of neuropeptides: Pepride α-amidation. Annu Rev Neurosci 15: 57-85, 1992
135. Martínez A, Montuenga LM, Springall DR, Treston A Cuttitta F, Polak JM: Immunocytochemical localization of peptidylglycine alpha-amidating monooxygenase enzymes (PAM) in human endocrine pancreas. J Histochem Cytochem 41: 375-380, 1993
136. Steel JH, Martínez A, Springall DR, Treston AM, Cuttitta F, Polak JM: Peptidylglycine α-amidating monooxygenase immunoreactivity and messenger RNA in human pituitary and increased expression in pituitary tumours. Cell Tissue Res 276: 197-207, 1994
137. Saldise L, Martínez A, Montuenga LM, Treston A, Springall DR, Polak JM, Vazquez JJ: Distribution of peptidylglycine alpha-amidating monooxygenase (PAM) enzymes in normal lung and in lung epithelial tumors. J Histochem Cytochem 44: 3-12, 1996
138. Treston AM, Mulshine JL, Cuttitta F: Control of tumour cell biology through regulation of peptide hormone processing. Monogr Natl Cancer Inst 13: 169-175, 1992
139. Steel JH, Treston A, Cuttitta F, Polak JM: Peptidylglycine α-amidating monooxygenase immunoreactivity is present in sustentacular cells and folliculo-stellate cells in human neuroendocrine tumours. J Pathol 175 (Suppl): 137A, 1995
140. Allaerts W, Carmeliat P, Denef C: New perspectives in the function of pituitary folliculo-stellate cells. Mol Cell Endocrinol 71: 73-81, 1990
141. Lloyd RV, Blaivas M, Wilson BS: Distribution of chromogranin and S-100 protein in normal and abnormal adrenamedullary tissues. Arch Pathol Lab Med 109: 633-635, 1985
142. Achilles E, Padberg B-C, Holl K, Kloppel G, Schroder S Immunocytochemistry of paragangłiomas - value of staining for S-100 protein and glial fibrillary acidic protein in diagnosis and prognosis. Histopathology 18: 453-458, 199
143. Barbareschi M, Frigo B, Mosca L, Carboni N, Arrigoni GF Leonardi E, Wilander E, Siegal GP, Shiro BC: Bronchia carcinoids with S-100 positive sustentacular cells. A comparative study with gastrointestinal carcinoids, phaeochromocytomas and paragangliomas. Pathol Res Pract 186 212-222, 1990
144. Gosney JR, Denley H, Resl M, Beesley C: Sustentacula cells in bronchial carcinoid tumours. J Pathol 173 (Suppl 179A, 1994
145. Lauriola L, Cocchia D, Sentinelli S, Maggiano N, Maira C Michetti F: Immunohistochemical detection of follicular stellate cells in human pituitary adenomas. Virchows Arch (Cell Pathol) 47: 189-197, 1984
146. Turpin G, Heshmati HM, Kujas M, Gremain J, Jacque CM, Racadot J: Immunocytochemical study of S-100 protein in human pituitary adenomas. Virchows Archiv B Cell Pathol 55: 107-109, 1988
147. Inoue K, Matsumoto H, Koyama C, Shibata K, Nakazato Y, Ito A: Establishment of a folliculo-stellate-cell line from a murine thyrotropic pituitary tumor. Endocrinology 131: 3110-3116, 1992
148. Koyama C, Matsumoto H, Sakai T, Wakabayashi K, Ito A, Couch EF, Inoue K: Pituitary folliculo-stellate-like cells stimulate somatotropic tumor growth in nude mice. Endoer Pathol 6: 67-75, 1995
149. Singh P, Xu Z, Dai B, Rajaraman S, Ruhin N, Dhruva B: Incomplete processing of progastrin expressed by human colon cancer cells: Role of noncarboxyamidated gastrins. Am J Physiol 266: G459-G468, 1994